Syncom Formulation (India) Overview
- Year Founded
-
1988
- Status
-
Public
- Employees
-
1,324
- Stock Symbol
-
524470
- Share Price
-
$0.20
- (As of Friday Closing)
Syncom Formulation (India) General Information
Description
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.
Contact Information
Website
www.syncomformulations.comCorporate Office
- Off Mahakali Caves Road
- 7, Niraj industrial Estate, Andheri (East)
- Mumbai, Maharashtra 400093
- India
Corporate Office
- Off Mahakali Caves Road
- 7, Niraj industrial Estate, Andheri (East)
- Mumbai, Maharashtra 400093
- India
Syncom Formulation (India) Stock Performance
As of 16-May-2025, Syncom Formulation (India)’s stock price is $0.20. Its current market cap is $193M with 940M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.20 | $0.20 | $0.13 - $0.33 | $193M | 940M | 461K |
Syncom Formulation (India) Financials Summary
As of 31-Dec-2024, Syncom Formulation (India) has a trailing 12-month revenue of $46.2M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 209,859 | 128,267 | 70,934 | 116,651 |
| Revenue | 46,198 | 31,315 | 27,708 | 29,235 |
| EBITDA | 6,424 | 4,533 | 3,683 | 3,761 |
| Net Income | 4,678 | 3,058 | 2,500 | 2,656 |
| Total Assets | 48,525 | 46,020 | 40,650 | |
| Total Debt | 0 | 8,692 | 10,132 | 7,621 |
Syncom Formulation (India) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Syncom Formulation (India) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Syncom Formulation (India) FAQs
-
When was Syncom Formulation (India) founded?
Syncom Formulation (India) was founded in 1988.
-
Where is Syncom Formulation (India) headquartered?
Syncom Formulation (India) is headquartered in Mumbai, India.
-
What is the size of Syncom Formulation (India)?
Syncom Formulation (India) has 1,324 total employees.
-
What industry is Syncom Formulation (India) in?
Syncom Formulation (India)’s primary industry is Pharmaceuticals.
-
Is Syncom Formulation (India) a private or public company?
Syncom Formulation (India) is a Public company.
-
What is Syncom Formulation (India)’s stock symbol?
The ticker symbol for Syncom Formulation (India) is 524470.
-
What is the current stock price of Syncom Formulation (India)?
As of 16-May-2025 the stock price of Syncom Formulation (India) is $0.20.
-
What is the current market cap of Syncom Formulation (India)?
The current market capitalization of Syncom Formulation (India) is $193M.
-
What is Syncom Formulation (India)’s current revenue?
The trailing twelve month revenue for Syncom Formulation (India) is $46.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
